MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: single-center retrospective study in 56 patients
PurposeWe aimed to evaluate the advantages of magnetic resonance angiography (MRA)-planned prostatic artery embolization (PAE) for benign prostatic hyperplasia (BPH).MethodsIn this retrospective study, MRAs of 56 patients (mean age, 67.23±7.73 years; age range, 47–82 years) who underwent PAE between...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2021-11-01
|
| Series: | Diagnostic and Interventional Radiology |
| Online Access: |
http://www.dirjournal.org/archives/archive-detail/article-preview/mr-angiography-planned-prostatic-artery-embolizati/53799
|
| _version_ | 1797691355931082752 |
|---|---|
| author | Thomas J. Vogl Annette Zinn Elsayed Elhawash Leona S. Alizadeh Nour-Eldin A. Nagy N.N. Naguib |
| author_facet | Thomas J. Vogl Annette Zinn Elsayed Elhawash Leona S. Alizadeh Nour-Eldin A. Nagy N.N. Naguib |
| author_sort | Thomas J. Vogl |
| collection | DOAJ |
| description | PurposeWe aimed to evaluate the advantages of magnetic resonance angiography (MRA)-planned prostatic artery embolization (PAE) for benign prostatic hyperplasia (BPH).MethodsIn this retrospective study, MRAs of 56 patients (mean age, 67.23±7.73 years; age range, 47–82 years) who underwent PAE between 2017 and 2018 were evaluated. For inclusion, full information about procedure time and radiation values must have been available. To identify prostatic artery (PA) origin, three-dimensional MRA reconstruction with maximum intensity projection was conducted in every patient. In total, 33 patients completed clinical and imaging follow-up and were included in clinical evaluation.ResultsThere were 131 PAs with a second PA in 19 pelvic sides. PA origin was correctly identified via MRA in 108 of 131 PAs (82.44%). In patients in which MRA allowed a PA analysis, a significant reduction of the fluoroscopy time (-27.0%, p = 0.028) and of the dose area product (-38.0%, p = 0.003) was detected versus those with no PA analysis prior to PAE. Intervention time was reduced by 13.2%, (p = 0.25). Mean fluoroscopy time was 30.1 min, mean dose area product 27,749 µGy•m2, and mean entrance dose 1553 mGy. Technical success was achieved in all 56 patients (100.0%); all patients were embolized on both pelvic sides. The evaluated data documented a significant reduction in IPSS (p < 0.001; mean 9.67 points).ConclusionMRA prior to PAE allowed the identification of PA in 82.44% of the cases. MRA-planned PAE is an effective treatment for patients with BPH. |
| first_indexed | 2024-03-12T02:13:08Z |
| format | Article |
| id | doaj.art-61117eeced084a02b77099500f65decb |
| institution | Directory Open Access Journal |
| issn | 1305-3825 1305-3612 |
| language | English |
| last_indexed | 2024-03-12T02:13:08Z |
| publishDate | 2021-11-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | Diagnostic and Interventional Radiology |
| spelling | doaj.art-61117eeced084a02b77099500f65decb2023-09-06T12:17:13ZengGalenos Publishing HouseDiagnostic and Interventional Radiology1305-38251305-36122021-11-0127672573110.5152/dir.2021.2012413049054MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: single-center retrospective study in 56 patientsThomas J. Vogl0Annette Zinn1Elsayed Elhawash2Leona S. Alizadeh3Nour-Eldin A.4Nagy N.N. Naguib5 Institute of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany Institute of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany Institute of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany Institute of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany Institute of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany Department of Radiology, AMEOS Hospital Halberstadt, Halberstadt, Germany PurposeWe aimed to evaluate the advantages of magnetic resonance angiography (MRA)-planned prostatic artery embolization (PAE) for benign prostatic hyperplasia (BPH).MethodsIn this retrospective study, MRAs of 56 patients (mean age, 67.23±7.73 years; age range, 47–82 years) who underwent PAE between 2017 and 2018 were evaluated. For inclusion, full information about procedure time and radiation values must have been available. To identify prostatic artery (PA) origin, three-dimensional MRA reconstruction with maximum intensity projection was conducted in every patient. In total, 33 patients completed clinical and imaging follow-up and were included in clinical evaluation.ResultsThere were 131 PAs with a second PA in 19 pelvic sides. PA origin was correctly identified via MRA in 108 of 131 PAs (82.44%). In patients in which MRA allowed a PA analysis, a significant reduction of the fluoroscopy time (-27.0%, p = 0.028) and of the dose area product (-38.0%, p = 0.003) was detected versus those with no PA analysis prior to PAE. Intervention time was reduced by 13.2%, (p = 0.25). Mean fluoroscopy time was 30.1 min, mean dose area product 27,749 µGy•m2, and mean entrance dose 1553 mGy. Technical success was achieved in all 56 patients (100.0%); all patients were embolized on both pelvic sides. The evaluated data documented a significant reduction in IPSS (p < 0.001; mean 9.67 points).ConclusionMRA prior to PAE allowed the identification of PA in 82.44% of the cases. MRA-planned PAE is an effective treatment for patients with BPH. http://www.dirjournal.org/archives/archive-detail/article-preview/mr-angiography-planned-prostatic-artery-embolizati/53799 |
| spellingShingle | Thomas J. Vogl Annette Zinn Elsayed Elhawash Leona S. Alizadeh Nour-Eldin A. Nagy N.N. Naguib MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: single-center retrospective study in 56 patients Diagnostic and Interventional Radiology |
| title | MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: single-center retrospective study in 56 patients |
| title_full | MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: single-center retrospective study in 56 patients |
| title_fullStr | MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: single-center retrospective study in 56 patients |
| title_full_unstemmed | MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: single-center retrospective study in 56 patients |
| title_short | MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: single-center retrospective study in 56 patients |
| title_sort | mr angiography planned prostatic artery embolization for benign prostatic hyperplasia single center retrospective study in 56 patients |
| url |
http://www.dirjournal.org/archives/archive-detail/article-preview/mr-angiography-planned-prostatic-artery-embolizati/53799
|
| work_keys_str_mv | AT thomasjvogl mrangiographyplannedprostaticarteryembolizationforbenignprostatichyperplasiasinglecenterretrospectivestudyin56patients AT annettezinn mrangiographyplannedprostaticarteryembolizationforbenignprostatichyperplasiasinglecenterretrospectivestudyin56patients AT elsayedelhawash mrangiographyplannedprostaticarteryembolizationforbenignprostatichyperplasiasinglecenterretrospectivestudyin56patients AT leonasalizadeh mrangiographyplannedprostaticarteryembolizationforbenignprostatichyperplasiasinglecenterretrospectivestudyin56patients AT noureldina mrangiographyplannedprostaticarteryembolizationforbenignprostatichyperplasiasinglecenterretrospectivestudyin56patients AT nagynnnaguib mrangiographyplannedprostaticarteryembolizationforbenignprostatichyperplasiasinglecenterretrospectivestudyin56patients |